SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
COHEN JOEL CHARLES

(Last) (First) (Middle)
2800 COTE VERTU, #106

(Street)
MONTREAL A8 H4R 2M5

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
04/28/2006
3. Issuer Name and Ticker or Trading Symbol
IntelGenx Technologies Corp. [ IGXT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CFO
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares 1,571,713 I See Footnote(1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option (Right to buy) 05/15/2007 11/15/2016 Common Shares 62,500 $0.41 D
Option (Right to buy) 11/15/2007 11/15/2016 Common Shares 62,500 $0.41 D
Option (Right to buy) 05/15/2008 11/15/2016 Common Shares 62,500 $0.41 D
Option (Right to buy) 11/15/2008 11/15/2016 Common Shares 62,500 $0.41 D
Explanation of Responses:
1. The issuer acquired a subsidiary, IntelGenx Corp.,in April of 2006. As part of this Acquisition, Joel Cohen became CFO and Director of the Issuer and acquired 1,571,713 exchangeable shares of the Company's Canadian subsidiary,6544631 Canada Inc. These 1,571,713 shares are exchangeable, on a one for one basis, into shares of common stock of the Issuer at Joel Cohen's discretion. Prior to exchanging the exchangeable shares for shares of the issuer, Joel Cohen has the right to vote 1,571,713 shares of the Issuer. It is because of these vote rights, which indicate control over the shares, that these shares are included on this Form 3. The 1,571,713 shares of the Issuer have not been registered for resale at this time. The acquisition and the terms under which the exchangable shares were issued are more completely described in the Issuer's Report on the SB2 filed on July 3, 2006.
Joel Cohen 12/13/2006
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.